GlassScriptPhysician profile
Jenny Chau
NPI 1093567083
$1,152.32
in general payments reported to CMS, 2019-2025
17 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $967 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,092 · Education: $59.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,092.33 |
| Education | $59.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $262.75 | 2024 | Cimzia, Bimzelx |
| Amgen INC. | $203.64 | 2024 | Otezla, Enbrel, Tavneos |
| Mallinckrodt Hospital Products INC. | $158.28 | 2024 | Acthar |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $98.80 | 2025 | Caplyta |
| Alkermes, INC. | $58.41 | 2025 | Vivitrol |
| Aurinia Pharma U.S., INC. | $57.88 | 2024 | Lupkynis |
| Glaxosmithkline, LLC. | $43.36 | 2024 | Benlysta |
| E.R. Squibb & Sons, L.L.C. | $39.05 | 2024 | Orencia |
| Genentech USA, INC. | $37.14 | 2024 | Actemra |
| Pfizer INC. | $34.95 | 2024 | |
| Actelion Pharmaceuticals US, INC. | $29.02 | 2024 | Uptravi, Opsumit |
| Alexion Pharmaceuticals, INC. | $28.67 | 2024 | |
| Abbvie INC. | $28.26 | 2025 | |
| Kyowa Kirin, INC. | $20.38 | 2024 | Crysvita |
| Organon LLC | $18.96 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.73 | 2024 | Cyltezo |
| Astrazeneca Pharmaceuticals LP | $15.04 | 2024 | Saphnelo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenny Chau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.